Clinical experience with cefonicid in respiratory tract infections

A. Facchini, S. Serra, N. Tisselli

Research output: Contribution to journalArticlepeer-review


Cefonicid (SK&F D-75073-Z2) in a single daily dose of 0.5 g or 1 g was administered i.m. to 12 patients with infections of the lower respiratory tract. Efficacy and safety were evaluated by means of clinical, radiological and laboratory criteria. The clinical and radiological response was satisfactory in all patients but one, who was suffering from pneumonia due to a strain of Proteus morganii resistant to cefonicid. No significant alterations of the laboratory tests were observed. Pain at the site of injection was reported by eight patients.

Original languageEnglish
Pages (from-to)707-710
Number of pages4
JournalDrugs under Experimental and Clinical Research
Issue number10
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology


Dive into the research topics of 'Clinical experience with cefonicid in respiratory tract infections'. Together they form a unique fingerprint.

Cite this